Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) FCF Margin (2024 - 2025)

Prime Medicine's FCF Margin history spans 2 years, with the latest figure at 3953.34% for Q4 2025.

  • For Q4 2025, FCF Margin fell 489672.0% year-over-year to 3953.34%; the TTM value through Dec 2025 reached 3512.05%, up 64548.0%, while the annual FY2025 figure was 3512.05%, 64548.0% up from the prior year.
  • FCF Margin reached 3953.34% in Q4 2025 per PRME's latest filing, down from 2880.49% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 943.38% in Q4 2024 to a low of 13009.09% in Q3 2024.